International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Valsartan 4-mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s): 329

Valsartan 4-mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Valsartan 4-mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, valsartan, oral suspension, hypertension, high blood pressure, heart failure, left ventricular dysfunction, cardiac disorders, heart disease

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Valsartan 4 mg/mL in Syrup NF Allen Loyd V Jr	Mar/Apr 2020 Pg. 139
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Bramwell Bethany L	Mar/Apr 2010 Pg. 108-111
Valsartan 4-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2008 Pg. 269
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Valsartan 16-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 237
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Harrington Catherine A, Cauffield Jacintha	Mar/Apr 2005 Pg. 117-119
Enalapril Maleate 1-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 221
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu	Mar/Apr 2014 Pg. 169-174
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 325
Return to Top